Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Michael Paul Capparelli"'
Autor:
Christopher M. Adams, Catherine Solovay, Muneto Mogi, Byron Li, Doug Bevan, Mitsunori Kato, Jonathan E. Grob, Erik Meredith, David B. Belanger, Powers James J, Philippe Bolduc, Louis Yang, Nan Ji, Michael Paul Capparelli, Donglei Liu, Christopher Towler, Ganesh Prasanna, Matthew H. Daniels, Takeru Ehara, Rebecca C. Stacy, Luciana Ferrara
Publikováno v:
Journal of Medicinal Chemistry. 61:2552-2570
Soluble guanylate cyclase (sGC), the endogenous receptor for nitric oxide (NO), has been implicated in several diseases associated with oxidative stress. In a pathological oxidative environment, the heme group of sGC can be oxidized becoming unrespon
Autor:
Feng Sun, David Thomas Parker, Friedrich Schuerch, Silvio Roggo, Xiaolin Li, Zachary Kevin Sweeney, Li Cao, Nicole Meier, Bernard Riss, Christian Guenat, Wei Li, Zhaobo Gao, Jiping Fu, Jibin Zhao, Subramanian Karur, Wang Ruidong, Andrew H. Weiss, Regis Denay, Alexey Rivkin, Su Xu, Harald Schroeder, Michael Paul Capparelli, Simon Ng, Quanbing Wu, Xin Xiong, Weikuan Li, Wosenu Mergo, Christopher Becker, Robert Lowell Simmons, Amy Lu, Gai Yu, Wenjian Xu, Peichao Lu, Nicolas Wenger, Christian Zürcher, Thomas Lochmann, Meiliana Tjandra, Alexandre Luneau, Hongyong Kim, Aregahegn Yifru, Yunshan Peng, Fabrice Gallou, Jianguang Zhou, Roger Aki Fujimoto, Michael Wang
Publikováno v:
Bioorganicmedicinal chemistry. 26(4)
Synthetic modification of cyclosporin A at P3-P4 positions led to the discovery of NIM258, a next generation cyclophilin inhibitor with excellent anti-hepatitis C virus potency, with decreased transporter inhibition, and pharmacokinetics suitable for
Autor:
Istvan J. Enyedy, Wanlin Yan, Vinayak Hosagrahara, Timothy A. McKinsey, Erik Meredith, Nicolas Soldermann, Keith A. Koch, Nikos Pagratis, Qingming Zhu, Robin Burgis, Olga Rozhitskaya, Michael Paul Capparelli, Richard B. Vega, Ji-Hu Zhang, Chang Rao, Lauren G. Monovich, Kimberley Beattie, Gabriel G. Gamber
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:1447-1451
The synthesis and preliminary studies of the SAR of novel 3,5-diarylazole inhibitors of Protein Kinase D (PKD) are reported. Notably, optimized compounds in this class have been found to be active in cellular assays of phosphorylation-dependant HDAC5
Autor:
Chang Rao, Vinayak Hosagrahara, Robin Burgis, Richard B. Vega, Erik Meredith, Craig F. Plato, Nicolas Soldermann, Gabriel G. Gamber, Clayton Springer, David B. Hood, Joseph Chapo, Michael Paul Capparelli, Lauren G. Monovich, Istvan J. Enyedy, Qingming Zhu, Keith A. Koch, Dillon Phan, Dipietro Lucian, Olga Rozhitskaya, Timothy A. McKinsey, Kimberly Beattie, Maurice Van Eis, Nikos Pagratis, Karl Miranda, Wendy Lee, Wanlin Yan, Douglas D. Lemon, Charles F. Jewell
Publikováno v:
Journal of Medicinal Chemistry. 53:5422-5438
The synthesis and biological evaluation of potent and selective PKD inhibitors are described herein. The compounds described in the present study selectively inhibit PKD among other putative HDAC kinases. The PKD inhibitors of the present study blunt
Autor:
Brigitte Wiedmann, Michael Wang, Andrew H. Weiss, Silvio Roggo, David Thomas Parker, Robert Elling, Jiping Fu, Zachary Kevin Sweeney, Markus Furegati, Kwan Leung, Robert Lowell Simmons, Aregahegn Yifru, Subramanian Karur, Yunshan Peng, Shengtian Yang, Roger Aki Fujimoto, Lili Xie, Alexey Rivkin, Michael Paul Capparelli, Linda Xiao, Imad Hanna, Charlotte Miault, Simon Ng, Christopher Becker, Wosenu Mergo, Theresa Kasprzyk, Dallas Bednarczyk, Peichao Lu, Mark Knapp, Meiliana Tjandra, Bo Zhou, Xiaolin Li, Wenjian Xu
Publikováno v:
Journal of medicinal chemistry. 57(20)
Nonimmunosuppressive cyclophilin inhibitors have demonstrated efficacy for the treatment of hepatitis C infection (HCV). However, alisporivir, cyclosporin A, and most other cyclosporins are potent inhibitors of OATP1B1, MRP2, MDR1, and other importan
Autor:
Ronald L. Goldberg, V. Blancuzzi, Michael R. Justice, Lijuan Zhu, Michael Paul Capparelli, Salvatore Spirito, L R Fryer, Brian J Carroll, J. R. Doughty, Erol K. Bayburt, Elizabeth O'Byrne, Robert Goldstein, Vishwas Ganu, Doug Wilson, Macpherson Lawrence J, David Thomas Parker, Richard Melton, Shou-Ih Hu
Publikováno v:
Journal of Medicinal Chemistry. 40:2525-2532
Structure-activity relationships of a lead hydroxamic acid inhibitor of recombinant human stromelysin were systematically defined by taking advantage of a concise synthesis that allowed diverse functionality to be explored at each position in a templ
Autor:
Erik Meredith, Michael Paul Capparelli, Gary Michael Ksander, Chang Rao, Robin Burgis, Julien Papillon, Lauren G. Monovich, Dean F. Rigel, Alok K. Singh, Arco Y. Jeng, Chii-Whei Hu, Karl Miranda, Daniel LaSala, Qian Liu, Fumin Fu, Michael E. Beil, Qi-Ying Hu, Patrick J. Morris
Publikováno v:
ACS medicinal chemistry letters. 4(12)
Aldosterone is a key signaling component of the renin-angiotensin-aldosterone system and as such has been shown to contribute to cardiovascular pathology such as hypertension and heart failure. Aldosterone synthase (CYP11B2) is responsible for the fi
Autor:
Jane Peppard, Angelo J. Trapani, Frank H Clarke, Macpherson Lawrence J, Erol K. Bayburt, Yumi Sakane, Michael Paul Capparelli, Carol Berry, R. D. Ghai, Regine Bohacek
Publikováno v:
Journal of Medicinal Chemistry. 36:3821-3828
A potent macrocyclic inhibitor of neutral endopeptidase (NEP) 24.11 was designed using a computer model of the active site of thermolysin. This 10-membered ring lactam represents a general mimic for any hydrophobic dipeptide in which the two amino ac
Autor:
Kirk Clark, Regine Bohacek, Andrew Wigg, Robert Goldstein, Z. Fang, J. R. Doughty, John Fitt, Leslie Wighton Mcquire, Michael Paul Capparelli, David Farley, Zhengming Du, Ronald L. Goldberg, Anna K. Knap, Scott Douglas Cowen, Paul D. Greenspan, William Macchia, David E. Coppa, J. H. van Duzer, Tommasi Ruben A, Lijuan Zhu, Huanghai Zhou
Publikováno v:
Journal of medicinal chemistry. 44(26)
Cathepsin B is a member of the papain superfamily of cysteine proteases and has been implicated in the pathology of numerous diseases, including arthritis and cancer. As part of an effort to identify potent, reversible inhibitors of this protease, we
Autor:
Keith A. Koch, Timothy A. McKinsey, Dillon Phan, Chang Rao, David B. Hood, Lauren G. Monovich, Joseph A. Chapo, Richard B. Vega, Karl Miranda, Douglas D. Lemon, Erik Meredith, Michael Paul Capparelli
Publikováno v:
FEBS Letters. (3):631-637
Class IIa histone deacetylases (HDACs) repress genes involved in pathological cardiac hypertrophy. The anti-hypertrophic action of class IIa HDACs is overcome by signals that promote their phosphorylation-dependent nuclear export. Several kinases hav